FOLR2 and type 2 diabetes mellitus: A previous study revealed that FRB modulated the composition of the gut microbiota, especially enriching SCFA-producing bacteria such as Dubosiella and Lactobacillus and also increasing the SCFA levels in type 2 diabetic mice [35].